In addition, there is evidence that PTEN may regulate more aspects of the cancer’s behavior independently of the PI3K-AKT-mTOR pathway, affecting the tumoral microenvironment and immunomodulation that may affect the clinical response to immunotherapy [50,51,104]. Here, MTOR is linked to cancer.